Analysts’ Top Healthcare Picks: Revolution Medicines (RVMD), Incyte (INCY)
TipRanks (Mon, 9-Mar 9:21 AM ET)
Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Doximity (DOCS)
TipRanks (Mon, 9-Mar 7:05 AM ET)
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights
Globe Newswire (Thu, 12-Feb 1:00 PM ET)
Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fifth Consecutive Year
Business Wire (Thu, 5-Feb 4:05 PM ET)
Doximity Announces Fiscal 2026 Third Quarter Financial Results
Business Wire (Thu, 5-Feb 4:01 PM ET)
Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026
Business Wire (Thu, 15-Jan 4:01 PM ET)
HALPER SADEH LLC ENCOURAGES DOXIMITY INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
PRNewswire (Wed, 24-Dec 10:44 AM ET)
Market Chameleon (Mon, 15-Dec 3:37 AM ET)
Healthcare AI Exits Pilot Phase, Enters Production Deployment
Globe Newswire (Fri, 12-Dec 9:59 AM ET)
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
Doximity Class A trades on the NYSE stock market under the symbol DOCS.
As of March 11, 2026, DOCS stock price declined to $24.64 with 1,787,717 million shares trading.
DOCS has a beta of 1.35, meaning it tends to be more sensitive to market movements. DOCS has a correlation of 0.19 to the broad based SPY ETF.
DOCS has a market cap of $4.62 billion. This is considered a Mid Cap stock.
Last quarter Doximity Class A reported $185 million in Revenue and $.46 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.06.
In the last 3 years, DOCS traded as high as $85.21 and as low as $19.71.
The top ETF exchange traded funds that DOCS belongs to (by Net Assets): VTI, IJH, VB, VBK, VXF.
DOCS has underperformed the market in the last year with a return of -59.2%, while the SPY ETF gained +21.9%. In the last 3 month period, DOCS fell short of the market, returning -45.3%, while SPY returned -1.3%. However, in the most recent 2 weeks DOCS has outperformed the stock market by returning +2.4%, while SPY returned -1.6%.
DOCS support price is $23.87 and resistance is $25.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOCS shares will trade within this expected range on the day.